Weight loss and diabetes drugs

'Fake Ozempic' warning to Brits seeking to shed Christmas pounds, as criminals peddle dangerous counterfeit drugs

FDA: Eli Lilly weight loss drug Zepbound no longer in shortage

Veronvy - MARCS-CMS 694688

Prime Vitality, Inc. dba Prime Peptides - MARCS-CMS 695156

Summit Research Peptides - MARCS-CMS 695607

Warning Letter Xcel Research LLC - MARCS-CMS 694608

Woman accused of selling black market weight loss drugs, police say

Urgent warning issued over counterfeit Ozempic drug flooding the market that can have life-threatening implications

The American Diabetes Association announces statement on compounded incretin products

Compounded GLP 1 and Dual GIP/GLP 1 Receptor Agonists: A Statement from the American Diabetes Association | Diabetes Care | American Diabetes Association

Exclusive: Thousands turn to Wegovy copies each month as FDA considers shortage status

Drugmakers battle pharmacies over compounded Ozempic and Zepbound

The FDA's risky action on compounding weight loss drugs

Customs discover numerous illegal goods in flood of parcels | blue News

Scots mum, 31, hospitalised after one weight loss injection 'to lose a few pounds for holiday' as cops probe salon | The Scottish Sun

You're being lied to about Ozempic

Urgent warning as fake Ozempic infiltrates South African market

Counterfeit weight loss drugs sold online, feeding demand for cheaper options - CBS News

Novo Nordisk asks US to stop compounding pharmacies from making weight-loss drug copies

Novo Nordisk aware of reports 10 people taking compounded weight-loss drug copies died

US FDA says lowest dose of Novo Nordisk's weight-loss drug now available

Eli Lilly weight loss drug shortage underscores issues with FDA oversight

UK regulator tells doctors to watch for obesity injection misuse

MHRA reminds healthcare professionals to advise patients of the side effects of GLP-1 agonists and to report misuse

Eli Lilly sues over copycats of Zepbound weight loss drug

District of Vermont | California man pleads guilty to selling unapproved drugs with intent to defraud over the internet | United States Department of Justice

There's a big Ozempic controversy brewing online. Doctors say it's the 'wild west'

The crackdown on compounded GLP-1 meds has begun

Compounders sues FDA for removing Eli Lilly's tirzepatide from shortage list

Inside Eli Lilly's fight against counterfeit drugs